BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Oncology

Allink Biotherapeutics Secures $42 Million Series A Funding to Drive Global Expansion of Next-Gen ADC and Bispecific Antibody Therapies

Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutic...

November 29, 2024 | News

Viz.ai Partners with Microsoft to Advance AI-Powered Disease Detection and Care Coordination in Healthcare

Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Microsoft to deliver its AI models...

November 28, 2024 | News

Kelun-Biotech Secures China’s First Approval for TROP2-Directed ADC Sacituzumab Tirumotecan for Advanced Triple-Negative Breast Cancer

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from ...

November 28, 2024 | News

Lunit Partners with Mexico's Salud Digna to Advance AI-Driven Cancer Diagnostics Across Latin America

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a strategic partnership with&nbs...

November 28, 2024 | News

QIAGEN’s QIAcuityDx Digital PCR System Approved by ARTG to Enhance Clinical Diagnostics Across Australia and New Zealand

Provides absolute quantitation, essential for precise monitoring of low-abundance targets in clinical diagnostics Enhances lab effic...

November 26, 2024 | News

Akeso's Penpulimab and Anlotinib Combo Accepted by NMPA for First-Line Advanced Liver Cancer Treatment

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accep...

November 25, 2024 | News

Kura Oncology and Kyowa Kirin Forge $1.5 Billion Global Partnership for Ziftomenib in AML Across U.S., Japan, and International Markets

Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in ...

November 21, 2024 | News

Mongolian Health Officials Tour SD Biosensor Facilities in Korea to Strengthen Infectious Disease Collaboration

A team of officials from the National Center for Communicable Diseases, Mongolia (NCCD), had a tour around the Cheongju and Jeungpyeong Factori...

November 21, 2024 | News

Lunit and AstraZeneca Collaborate in South Korea to Transform Lung Cancer Diagnostics with AI-Powered Genotype Predictor

Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations Lunit (KRX:3281...

November 19, 2024 | News

SK Biopharmaceuticals Partners with KIRAMS to Advance Radiopharmaceutical Cancer Therapies Using Actinium-225

SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates...

November 19, 2024 | News

BeiGene Rebrands as BeOne Medicines, Embracing a United Vision to Defeat Cancer Globally

The new name reflects a bold vision to eradicate cancer by leveraging the transformative power of global collaboration and multi-sectoral partn...

November 18, 2024 | News

Lilly’s SGD$42 Million AI-Driven Digital Health Hub in Singapore Set to Transform Global Research in Cardio, Neuro, and Oncology

Lilly to drive next-generation AI powered digital health technology research in Singapore Lilly Digital ...

November 15, 2024 | News

Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility

In an exclusive interview with BioPharma APAC, Pam Cheng, Executive Vice President of Global Operations & IT and Chief Sustainability Officer at AstraZ...

November 15, 2024 | Interview

Transgene and NEC Unveil Positive 24-Month Data for TG4050 Cancer Vaccine in Adjuvant Treatment of Head and Neck Cancer at SITC 2024

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Cor...

November 14, 2024 | News

Stay Connected